Eko Health’s AI for Cardiac Diagnoses Earns CMS Reimbursement Rate - MedCity News
Eko Health's AI for cardiac diagnoses has received a CMS reimbursement rate, enabling healthcare providers to receive payment for its use.
Aforeworn detected this change in the Healthcare AI Regulation (FDA / ONC) space on August 22, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Health systems and medical device companies utilizing Eko Health's AI technology. should confirm how it applies to their specific situation before acting. There is a time constraint attached: No specific deadline mentioned.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Healthcare AI Regulation (FDA / ONC) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
CMS has established a reimbursement rate for Eko Health's AI cardiac diagnosis tool.
Who it affects
Health systems and medical device companies utilizing Eko Health's AI technology.
What you must do
Integrate Eko Health's AI into clinical workflows to qualify for reimbursement.
Deadline
No specific deadline mentioned.
Never miss a change like this again
Aforeworn watches Healthcare AI Regulation (FDA / ONC) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Healthcare AI Regulation (FDA / ONC)
- California Enacts SB 53: A Defining Step in Responsible AI Governance for Frontier AI Developers - JD Supra
- Illinois Gov. Pritzker inks legislation prohibiting AI therapy - MobiHealthNews
- Green approves bills that crack down on artificial intelligence - Hawaii Public Radio
- FDA Issues AI Guidance for Wearables, Decision Support Tools - MeriTalk
- New California AI Laws Taking Effect in 2026 - JD Supra